These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18468207)

  • 1. Rehabilitation of patients with implantable cardioverter/defibrillator: a literature review.
    Hussein NA; Thomas MA
    Acta Cardiol; 2008 Apr; 63(2):249-57. PubMed ID: 18468207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillator therapy in athletes.
    Heidbüchel H
    Cardiol Clin; 2007 Aug; 25(3):467-82, vii. PubMed ID: 17961801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should an implanted defibrillator be considered in patients with vasospastic angina?
    Eschalier R; Souteyrand G; Jean F; Roux A; Combaret N; Saludas Y; Clerfond G; Barber-Chamoux N; Citron B; Lusson JR; Brugada P; Motreff P
    Arch Cardiovasc Dis; 2014 Jan; 107(1):42-7. PubMed ID: 24373622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP
    Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillators: risks accompany the life-saving benefits.
    Atwater BD; Daubert JP
    Heart; 2012 May; 98(10):764-72. PubMed ID: 22422588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phantom shocks in patients with implantable cardioverter defibrillator: results from a randomized rehabilitation trial (COPE-ICD).
    Berg SK; Moons P; Zwisler AD; Winkel P; Pedersen BD; Pedersen PU; Svendsen JH
    Europace; 2013 Oct; 15(10):1463-7. PubMed ID: 23599170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden death risk in syncope: the role of the implantable cardioverter defibrillator.
    Olshansky B; Sullivan RM
    Prog Cardiovasc Dis; 2013; 55(4):443-53. PubMed ID: 23472783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implantable cardioverter-defibrillator: An update.
    Miller JD; Yousuf O; Berger RD
    Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M;
    Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden cardiac death: prevention and treatment.
    Kwok KM; Lee KL; Lau CP; Tse HF
    Hong Kong Med J; 2003 Oct; 9(5):357-62. PubMed ID: 14530531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.